HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BMS Extends Choice Line For Diabetics With Foot Care, Oral Care Items

This article was originally published in The Tan Sheet

Executive Summary

Bristol-Myers Squibb plans to extend its Choice DM line of products for people with diabetes to include foot care and oral care items, as well as nutritional bars and shakes, the firm announced at the National Association of Chain Drug Stores Marketplace in San Diego June 8-10

You may also be interested in...



Hi-Tech Diabetic Products To Play Key Role In Firm’s Growth Strategy

Hi-Tech Pharmacal plans to build up its Health Care Products Division through a two-pronged approach involving launching new products aimed at diabetics and expanding distribution channels

Excedrin Quick Tabs Will Be On OTC Shelves By Labor Day

Bristol-Myers Squibb will back the upcoming launch of Excedrin Quick Tabs with a six-month, $20 mil. advertising/marketing campaign, the firm said at the National Association of Chain Drug Stores Marketplace Conference in San Diego, Calif. June 15-18

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

RS128807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel